$PMI

Picard Medical, Inc.

No enriched coverage for $PMI in the last 7 days.

No SEC Form 4 filings for $PMI in the last 30 days.

Med

Picard Medical revenue up 79.9% to USD 1.1M in Q1 2026

Picard Medical, Inc. announced preliminary, unaudited top-line revenues of $1.1 million for Q1 2026, marking a 79.9% increase from the previous year. This growth was attributed to higher utilization of the SynCardia Total Artificial Heart and increased driver rental income, driven by favorable reimbursement and economic conditions in the United States, along with pricing adjustments to their rental program. The company expects to file its full financial results by May 15, 2026.

Bragar Eagel & Squire Urges Picard Medical Investors to Contact Firm Before April 3 Deadline

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Picard Medical, Inc. (NYSE:PMI) alleging a fraudulent stock promotion scheme and insider trading. The lawsuit claims Picard failed to disclose that its stock price crash was due to misinformation and coordinated share dumping. Investors who purchased Picard securities between September 2, 2025, and October 31, 2025, are urged to contact the firm before the April 3, 2026, deadline to apply as lead plaintiff.

Deadline Alert: Picard Medical, Inc. (PMI) Shareholders Who

Glancy Prongay Wolke & Rotter LLP has issued a deadline alert for shareholders of Picard Medical, Inc. (PMI) who suffered losses between September 2, 2025, and October 31, 2025. Investors are urged to contact the firm regarding a securities fraud lawsuit alleging that Picard's stock was subject to an illicit social-media-based promotion scheme. The deadline to file a lead plaintiff motion is April 3, 2026.